
MDaaS Global: Tech-enabled diagnostic centers for underserved communities, promoting healthier lives.
MDaaS Global, founded with the mission to bridge the healthcare gap in clinically-underserved communities, operates tech-enabled diagnostic centers across Africa. The company focuses on providing modern, convenient, and affordable diagnostic services to low-income and middle-income patients. By facilitating early identification of health issues and connecting patients with medical specialists and treatment options, MDaaS Global aims to promote healthier and happier lives. Their ultimate vision is to become the largest integrated care network on the continent, driving healthcare innovation to improve the lives of all Africans.
Notable affiliated people include co-founders who are passionate about healthcare access and innovation. The company has garnered support from investors focused on social impact and healthcare technology. Key achievements include serving numerous patients, partnering with multiple clinical entities, and expanding their presence in several Nigerian cities. MDaaS Global's impact is significant, as it enhances healthcare accessibility and quality for underserved populations, contributing to better health outcomes across Africa.

Healthtracka
healthtracka.com

Insightiv Technologies

Dr.Online
dronline.com

Healthlane
healthlane.co

Digital Medical Tech

AlloDoc
doc.africa

Thinkmd
thinkmd.org

Cerebro Solutions

Ambit.AI
ambit.ai

MedPiper Technologies, Inc
medpiper.com

Clinify Health
clinifyhealth.com

Azra Care
azra.ai

MD Integrations
mdintegrations.com

Duality Health
duality.health

Frame Health
framehealth.com
Companies similar to MDaaS Global include Healthtracka, Insightiv Technologies, Dr.Online and Healthlane.
MDaaS Global was founded in 2016.
MDaaS Global's headquarters is located in Lagos, Lagos, NG.
MDaaS Global's most recent funding round was for $150k (USD) in June 2023.
As of Jun 20, 2023, MDaaS Global has raised a total of $4.1M (USD).
MDaaS Global has 36 employees as of Feb 5, 2024.